VAS Viasys Healthcare

VIASYS Healthcare Inc. (NYSE:VAS) is pleased to announce that Edward Pulwer, VIASYS� Chief Operating Officer, has assumed the additional role of Group President, VIASYS NeuroCare. Randy H. Thurman, Chairman, President and Chief Executive Officer, commented, �Ed has established an extraordinary track record in his 30 years in the medical technology industry. Ed previously led the respiratory diagnostics and critical care businesses within VIASYS. Following the successful implementation of his strategy, both of these businesses are now considered to be global technology and market leaders in their respective healthcare segments. Ed has proven himself to be an outstanding leader who delivers on his commitments in product development, sales and marketing and operational and financial performance. His early career included key leadership roles in sales and marketing. Most importantly, he has demonstrated his ability to build winning teams, integrate the best of all ideas and empower people of all levels." Mr. Thurman further commented, �VIASYS NeuroCare is committed to being a leading company worldwide in neurophysiology, audio and vascular diagnostics. In the last three years, VIASYS has made significant investments in research and development as well as technology acquisitions in these areas. Some of these investments may lead us into new therapeutic areas as well.� ABOUT VIASYS HEALTHCARE INC. VIASYS Healthcare Inc. is a global, research-based medical technology company focused on respiratory, neurology, medical disposable and orthopedic products. VIASYS products are marketed under well-recognized trademarks, including, among others, AVEA�, BEAR�, BIRD�, CORFLO�, CORPAK�, CORTRAK�, EME�, GRASON-STADLER�, JAEGER�, LYRA�, MEDELEC�, MICROGAS�, NAVIGATOR�, NICOLET�, NicoletOne�, PULMONETIC�, SENSORMEDICS�, TECA�, TECOMET�, VELA� and VMAX�. VIASYS is headquartered in Conshohocken, PA, and its businesses are conducted through its Respiratory Care, NeuroCare, MedSystems and Orthopedics business units. More information can be found at http://www.viasyshealthcare.com. This news release includes forward-looking statements within the meaning of the "Safe Harbor" provisions of Private Securities Litigation Reform Act of 1995 regarding VIASYS NeuroCare's commitment to being a leading company in certain areas and its investments leading it into new therapeutic areas. These forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including important factors that could delay, divert, or change the expectations for VIASYS� products and could cause actual outcomes and results to differ materially from current expectations. These factors include, among other things, market factors, internal research and development initiatives, partnered research and development initiatives, a successful merger and acquisition strategy, competitive product development, commercialization of new products, sales and marketing initiatives, governmental regulations and legislation, patent positions and litigation. For further details and a discussion of other risks and uncertainties that may change VIASYS' expectations, please see VIASYS� annual report on Form 10-K for the year ended December 30, 2006, which is on file with the Securities and Exchange Commission. VIASYS undertakes no obligation to publicly update this forward-looking statement, whether as a result of new information, future events, or otherwise.